Skip to search formSkip to main contentSkip to account menu

actoxumab

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Antibodies, NeutralizingMonoclonal Antibodies

Narrower (1)

MK-3415

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
591 HUMAN BIOPSY-DERIVED COLONOIDS ARE USEFUL TO STUDY LUMINAL C DIFFICILE INFECTION AND THE RELATIVE BENEFIT OF ACTOXUMAB OR BEZLOTOXUMAB.
2017
2017
The Rising Incidence of C. difficile and Bezlotoxumab: The Targeting of Toxin B
Clostridium difficile ( C. difficile ) infection has become a growing issue facing hospitals in North America and Europe. Each… 
2017
2017
In C difficile infection, adding IV bezlotoxumab to standard antibiotics reduced recurrence at 12 weeks
Question In patients with Clostridium difficile infection (CDI), does adding bezlotoxumab, with or without actoxumab, to standard… 
2015
2015
Bezlotoxumab (BEZ) Alone and With Actoxumab (ACT) for Prevention of Recurrent C. difficile Infection (rCDI) in Patients on Standard of Care (SoC) Antibiotics: Integrated Results of 2 Phase 3 Studies…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)